Centre for Genomic Pathogen Surveillance

The Centre for Genomic Pathogen Surveillance is a computational genomics research institute in Oxfordshire.

History

The Centre for Genomic Pathogen Surveillance opened in 2015 as a joint project between Imperial College London and Wellcome Sanger Institute. In 2017 it was announced that the centre would house a new Global Health Research Unit funded by the National Institute for Health Research to look at antibiotic resistance. This has seen the centre becoming involved with surveillance of antibiotic resistance in a number of countries, for example, the Philippines.
From 2018 to 2021 the Wellcome Sanger Institute and University of Oxford co-hosted the CGPS. From September 2021 the CGPS has been based at the University of Oxford.
During the COVID-19 pandemic, the centre received funding as part of the COG-UK consortium.
On 22 September 2022 it was announced that the Centre for Genomic Pathogen Surveillance, part of the Big Data Institute at the University of Oxford, was awarded funding worth £7m for their work as an NIHR Global Health Research Unit for the next five years. The Centre’s research and capacity building work focuses on delivering genomics and enabling data for the surveillance of antimicrobial resistance.

The centre's director is David Aanensen.
In 2019, it was agreed that there would be collaboration between the Centre for Genomic Pathogen Surveillance, the European Centre for Disease Prevention and Control, and the Wellcome Sanger Institute, towards improving the monitoring and tracking of infectious diseases across Europe.

Under the auspices of the centre, the Epicollect5, Microreact, and Pathogenwatch applications have been generated and shared. Microreact has seen extensive use during the COVID-19 pandemic, and is a component of the Phylogenetic Assignment of Named Global Outbreak Lineages software tool.